Hapvida sets up share sale

Hapvida sets up share sale

Corporate & Sovereign Strategy Equity Capital Markets Latin America South America Brazil

Brazilian healthcare company Hapvida said Sunday it received board approval for a follow-on equity offering worth up to BRL2.68 billion ($469 million) to finance the acquisition of Notre Dame Intermédica and other deals. Hapvida will offer 100 million common shares in a primary offering and shareholders will sell 33.3 million in a secondary offering. Both offerings can be increased by 35%, or 35 million shares in the primary offering and 11.7 million in the second offering, the company said in a

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial